Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClean Power Hyd Regulatory News (CPH2)

  • This share is currently suspended. It was suspended at a price of 13.60

Share Price Information for Clean Power Hyd (CPH2)

Share Price is delayed by 15 minutes
Get Live Data
13.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £68.27m
CPH2 Live PriceLast checked at - London Stock Exchange

Intraday Clean Power Hyd Share Chart

Operational Update

21 Feb 2024 07:00

RNS Number : 8061D
Clean Power Hydrogen
21 February 2024
 

 

 

21 February 2024

Clean Power Hydrogen plc

("CPH2", the "Company" or the "Group")

Operational Update

Clean Power Hydrogen plc (AIM: CPH2), the UK-based green hydrogen technology and manufacturing group that has developed the IP-protected Membrane-Free Electrolyser ("MFE"), is pleased to announce that it has successfully completed its functional test of the Programme Logic Control ("PLC") of the MFE110 for Northern Ireland Water. The PLC represents the coded programme which automatically operates the MFE110 including shutdown, an important safety feature which originally caused the pausing of the MFE110 Factory Acceptance Test ("FAT") in November 2023.

The successful test was witnessed by Lagan MEICA Limited, the Contractor to Northern Ireland Water, and means the Factory Acceptance Test can progress to the final stages.

A Factory Acceptance Test will be the first customer acceptance and validation of CPH2's scaled electrolyser technology marking a significant milestone in the Company's journey. The PLC can also be used for the Company's 1MW system, the MFE220 which is the Company's flagship product.

 

Jon Duffy, CEO of Clean Power Hydrogen commented:

"The successful test of the Programme Logic Control allowing for fully automated operation, signifies an important part of the MFE110's journey to commercial production of hydrogen and medical grade oxygen. While the pausing of the FAT test in November 2023 due to issues regarding the shutdown mechanism were disappointing, I am extremely proud of the team for re-evaluating the important safety shut down measures, and successfully finding a solution which has put us back on track to completing the MFE110 for our customers in the very near-term future."

ENDS

 

For more information, please contact:

 

Clean Power Hydrogen plc

via Camarco

Jon Duffy, Chief Executive Officer

James Hobson, Chief Financial Officer

Cavendish Capital Markets Limited - NOMAD & Broker

Neil McDonald

+44 (0)131 220 9771

Peter Lynch

+44 (0)131 220 9772

Adam Rae

+44 (0)131 220 9778

Camarco PR

+ 44(0) 20 3757 4980

Billy Clegg

Owen Roberts

Lily Pettifar

 

To find out more, please visit: https://www.cph2.com

 

Overview of CPH2

CPH2 is the holding company of Clean Power Hydrogen Group Limited ("Clean Power") which has almost a decade of dedicated research and product development experience. This experience has resulted in the creation of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest LCOH in the market in relation to the production of green hydrogen. The Group's MFE technology is already commercially available and demonstrating cost efficiencies and technological advantages. CPH2 is listed on the AIM market and trades under the ticker LON:CPH2.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEALAEAEELEFA
Date   Source Headline
12th Dec 20225:14 pmRNSInvestment in ATOME Energy plc
6th Dec 20227:00 amRNSSenior Management Team Strengthened
22nd Nov 202211:06 amRNSSecond Price Monitoring Extn
22nd Nov 202211:00 amRNSPrice Monitoring Extension
22nd Nov 20229:00 amRNSPrice Monitoring Extension
22nd Nov 20227:00 amRNSOperational Update
4th Oct 20224:41 pmRNSSecond Price Monitoring Extn
4th Oct 20224:35 pmRNSPrice Monitoring Extension
23rd Sep 20227:00 amRNSInterim results
23rd Sep 20227:00 amRNSInterim results
7th Sep 20224:45 pmRNSHolding(s) in Company
5th Sep 20227:00 amRNSAppointment of James Hobson as CFO
5th Sep 20227:00 amRNSAgreement with KCA Deutag Group
24th Aug 20228:11 amRNSOperational Update
19th Jul 20225:55 pmRNSResult of AGM
19th Jul 20227:45 amRNSLicence Agreement with GHFG Ltd.
23rd Jun 20225:24 pmRNSNotice of 2022 Annual General Meeting
27th May 20227:00 amRNSGroup Annual Report and Financial Statements
29th Apr 202210:16 amRNSOperations Update
4th Apr 202212:15 pmRNSAdditional purchase order from existing customer
21st Mar 20227:00 amRNSNew purchase order from additional customer
21st Mar 20227:00 amRNSOperations Update
2nd Mar 20225:31 pmRNSHolding(s) in Company
1st Mar 20224:41 pmRNSSecond Price Monitoring Extn
1st Mar 20224:36 pmRNSPrice Monitoring Extension
1st Mar 202211:49 amRNSHolding(s) in Company
21st Feb 20224:21 pmRNSPDMR Dealing
16th Feb 20227:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.